Overall Survival and the Response to Radiotherapy among Molecular Subtypes of Breast Cancer Brain Metastases Treated with Targeted Therapies

Jacob A. Miller; Rupesh Kotecha; Manmeet S. Ahluwalia; Alireza M. Mohammadi; Samuel T. Chao; Gene H. Barnett; Erin S. Murphy; Michael A. Vogelbaum; Lilyana Angelov; David M. Peereboom; John H. Suh

doi:10.1002/cncr.30616

Overall Survival and the Response to Radiotherapy among Molecular Subtypes of Breast Cancer Brain Metastases Treated with Targeted Therapies

Jacob A. Miller, Rupesh Kotecha, Manmeet S. Ahluwalia, Alireza M. Mohammadi, Samuel T. Chao, Gene H. Barnett, Erin S. Murphy, Michael A. Vogelbaum, Lilyana Angelov, David M. Peereboom, John H. Suh

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cancer
Volume	123
DOIs	https://doi.org/10.1002/cncr.30616
State	Published - Jun 15 2017

Disciplines

Medicine and Health Sciences
Surgery
Pathology
Endocrinology

Access to Document

10.1002/cncr.30616License: Unspecified

Cite this

@article{69a274c89c37424a92023487aa1fcf5f,

title = "Overall Survival and the Response to Radiotherapy among Molecular Subtypes of Breast Cancer Brain Metastases Treated with Targeted Therapies",

author = "Miller, \{Jacob A.\} and Rupesh Kotecha and Ahluwalia, \{Manmeet S.\} and Mohammadi, \{Alireza M.\} and Chao, \{Samuel T.\} and Barnett, \{Gene H.\} and Murphy, \{Erin S.\} and Vogelbaum, \{Michael A.\} and Lilyana Angelov and Peereboom, \{David M.\} and Suh, \{John H.\}",

note = "Molecular subtypes appear to be prognostic for survival and predictive of the response to radiotherapy. TKIs were found to improve survival and local control, and may decrease the rate of distant failure. To preserve neurocognition, these results support a paradigm of upfront radiosurgery and HER2-d ...",

year = "2017",

month = jun,

day = "15",

doi = "10.1002/cncr.30616",

language = "American English",

volume = "123",

journal = "Cancer",

}

TY - JOUR

T1 - Overall Survival and the Response to Radiotherapy among Molecular Subtypes of Breast Cancer Brain Metastases Treated with Targeted Therapies

AU - Miller, Jacob A.

AU - Kotecha, Rupesh

AU - Ahluwalia, Manmeet S.

AU - Mohammadi, Alireza M.

AU - Chao, Samuel T.

AU - Barnett, Gene H.

AU - Murphy, Erin S.

AU - Vogelbaum, Michael A.

AU - Angelov, Lilyana

AU - Peereboom, David M.

AU - Suh, John H.

N1 - Molecular subtypes appear to be prognostic for survival and predictive of the response to radiotherapy. TKIs were found to improve survival and local control, and may decrease the rate of distant failure. To preserve neurocognition, these results support a paradigm of upfront radiosurgery and HER2-d ...

PY - 2017/6/15

Y1 - 2017/6/15

UR - https://pubmed.ncbi.nlm.nih.gov/28192598/

U2 - 10.1002/cncr.30616

DO - 10.1002/cncr.30616

M3 - Article

VL - 123

JO - Cancer

JF - Cancer

ER -

Overall Survival and the Response to Radiotherapy among Molecular Subtypes of Breast Cancer Brain Metastases Treated with Targeted Therapies

Disciplines

Access to Document

Other files and links

Cite this